Effects of a 5-lipoxygenase inhibitor (L-651,392) and leukotriene D4 antagonist (L-649,923) in two animal models of immediate hypersensitivity reactions.
D000818:Animals; D001091:Arachidonate Lipoxygenases / Q000037:antagonists & inhibitors*; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D006969:Hypersensitivity, Immediate / Q000188:drug therapy*; D016859:Lipoxygenase Inhibitors; D010640:Phenothiazines / Q000494:pharmacology*; D010654:Phenylbutyrates / Q000494:pharmacology*; D051381:Rats; D013189:SRS-A / Q000037:antagonists & inhibitors; D012453:Saimiri
D016859:Lipoxygenase Inhibitors; D010640:Phenothiazines; D010654:Phenylbutyrates; D013189:SRS-A; C050033:L 649923; C053726:4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one; D001091:Arachidonate Lipoxygenases